MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Is Increased Mineralisation of Putamen Relevant for Pathophysiology of Cervical Dystonia?

    Z. Kosutzka, M. Jezberova, I. Straka, P. Valkovic (Bratislava, Slovakia)

    Objective: To assess the susceptibility-weighted imaging in patients with idiopathic cervical dystonia Background: Susceptibility-weighted imaging (SWI) is an advanced MR imaging sequence that can be…
  • 2022 International Congress

    Defining minimal clinically important differences in Huntington’s disease: An anchor-based approach

    J. Hamilton, J. Mills, G. Stebbins, J. Long, R. Fuller, S. Sathe, M. Roche, C. Sampaio (Princeton, USA)

    Objective: This study aims to estimate the longitudinal minimal clinically important difference (MCID) for HD-relevant, cognitive, motor, and functional outcome measures. We used the new…
  • 2022 International Congress

    WATCH-PD: Baseline Phenotype and Longitudinal Digital Assessments in Early PD

    T. Kangarloo, E. Dorsey, P. Auinger, D. Volfson, J. Padmanabhan, B. Tracey, RS. Latzman, P. Artoni, Y. Gong, A. Best, J. Severson, D. Anderson, M. Kostrzebski, A. Stevenson, P. Wilmot, Y. Pohlson, J. Cosman, K. Praneeth Kilambi, J. Edgerton, J. Adams (Cambridge, USA)

    Objective: To provide a longitudinal profile of early Parkinson’s (PD) disease progression using clinical and digital measures, and to evaluate the extent to which digital…
  • 2022 International Congress

    Chorea Severity Change Over Time in Huntington Disease and by Huntington Disease Stage

    E. Furr Stimming, V. Sung, S. Reshef, R. Willock, R. Ribalov, S. Brighton, S. Leo (Houston, USA)

    Objective: To describe the evolution of chorea severity over time in individuals with Huntington disease (HD) stratified by Total Functional Capacity (TFC). Background: Chorea is…
  • 2022 International Congress

    Non-motor symptom characteristics in patients with essential tremor

    E. Jaakkola, E. Mäkinen, J. Joutsa, M. Eklund, S. Nuuttila, E. Honkanen, K. Lindholm, T. Noponen, T. Ihalainen, K. Murtomäki, T. Nojonen, R. Levo, T. Mertsalmi, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: The objective of this study was to evaluate non-motor symptoms in essential tremor (ET) and compare those to healthy controls (HCs). Background: ET is…
  • 2022 International Congress

    Evaluation of the association between total electrical energy delivered (TEED) and cognitive function six months after DBS in patients with Parkinson’s disease

    F. Ruggiero, F. Mameli, M. Dini, S. Marceglia, M. Prenassi, L. Borellini, F. Cogiamanian, E. Pirola, E. Zirone, D. Mellace, B. Capetti, L. Remore, G. Fiore, MR. Reitano, N. Maiorana, M. Locatelli, S. Barbieri, A. Priori, R. Ferrucci (Milan, Italy)

    Objective: We aimed to investigate the neuropsychological outcome six months after bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkison's disease (PD) patients and…
  • 2022 International Congress

    Cannabinoids for painful dystonia in corticobasal syndrome: a report of three patients

    G. Rizzo, P. Avoni, V. Donadio, R. Liguori (Bologna, Italy)

    Objective: We aimed to assess the efficacy of cannabinoids in painful dystonia of corticobasal syndrome (CBS) patients Background: The clinical phenotype of CBS includes limb…
  • 2022 International Congress

    USE OF NIGHT TIME CONTINUOUS SUBCUTANEOUS INFUSION OF APOMORPHINE (NCSAI) IN ADVANCED PARKINSON’S DISEASE: A SERIES OF 37 CASES.

    AK. Vargas Mendoza, B. López López, M. Díaz Castela, J. Molina Gil, P. Zunzunegui Arroyo, A. Criado Antón, ME. Suárez Sanmartín, C. García Fernández (Oviedo, Spain)

    Objective: The aim of this study is to evaluate the feasibility, efficacy and safety of NCSAI administration in patients with Advanced Parkinson disease (APD). Background:…
  • 2022 International Congress

    Diffusion MRI tractometry findings in Dystonia- A UK Biobank study

    C. Maciver, M. Wadon, G. Bailey, A. Schalkamp, C. Sandor, D. Jones, C. Tax, K. Peall (Cardiff, United Kingdom)

    Objective: To compare key white matter motor pathways between those diagnosed with dystonia and unaffected controls, using data collected by the UK Biobank, processed and…
  • 2022 International Congress

    Association of a new pathogenic variant of LRRK2 with modifying lysosomal genes in a family with Parkinson’s disease

    L. Vela-Desojo, M. Osuna-Lopez, C. Guerrero, A. Pascual, F. Palau, J. Hoenicka (Alcorcón, Spain)

    Objective: To characterize a Parkinson’s disease (PD) family with high recurrence of the disease. Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder in which…
  • « Previous Page
  • 1
  • …
  • 788
  • 789
  • 790
  • 791
  • 792
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley